Last updated on July 2019

Etokimab in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)


Brief description of study

A study to evaluate the safety and efficacy multiple doses of Etokimab in subjects with Chronic Rhinosinusitis with Nasal Polyps.

Detailed Study Description

This study is a Phase II, randomized, placebo controlled, double-blind, multi-dose study to evaluate the efficacy and safety of Etokimab in subjects with Chronic Rhinosinusitis with Nasal Polyps.

Clinical Study Identifier: NCT03614923

Find a site near you

Start Over

Advanced Research Institute, Inc.

New Port Richey, FL United States
4.51miles
  Connect »